Image Alt




Sponsors / Industry Partners

“Enhance chances of business development with global visibility and attracting new customers”

WOCOIO offers pharmaceutical companies, medtech enterprises and other institutions the opportunity to increase their visibility towards a selected target audience. We are committed to provide you an opportunity to make your presence tangible in front of the world’s key opinion leaders in classical and complementary oncology.

During the four days of the event, your exposure to your target group will leave a noticable footprint. Four predefined sponsorship categories are available and can be complemented with additional targeted sponsorhip opportunities. Furthermore, taylored solutions can be offered upon request. You will have ample options to sponsor the congress with the flexibility and customization that your business requires.

Reach the Experts

The congress’ worldwide approach allows you to target an international audience at a single spot. Since lunches and dinners will be provided at the event and at the center of the industry exhibition, you will experience an unusually high traffic at your booth and enjoy exceptional networking opportunities.

Since WOCOIO is proud to bring together the world’s leading experts in the field of Integrative Oncology, the impact for your business will radiate beyond the people that you physically meet. Our aim is to provide a platform for an international exchange, that is an incubator for new ideas and concepts that will provide a tangible improvement to patients’ care. Our sponsors are invited to play a key role in these aspirations.

Why Sponsor WOCOIO?

  • Increase your visibility in oncology, increase your sales.
  • Meet international key opinion leaders in the field of Integrative Oncology.
  • Use the platform for new product/service launch.
  • Ascertain opportunities for new partnerships.
  • Attend scientific sessions to keep updated with new discoveries in Integrative Oncology.
  • Enjoy several social events in the evening.  Exchange with participants, key opinion leaders and speakers.
  • Benefit from the visit to a hospital and a pharmaceutical production plant, both active in Integrative Oncology.

Become a Sponsor

If you want to become a sponsor at WOCOIO, please fill out this form and we will revert, shortly. 

Or send us an email at:

    Still Available Sponsorship Levels

    9,000 €

    Your logo on the website
    Your logo on advertising material
    Background Plenary lecture (20 mins)
    Email campaign
    Exhibition space (9 m²)
    Staff passes (4)
    Delegate passes (2)
    Supplements in delegate bags (2)

    5,000 €

    Your logo on the website
    Your logo on advertising material Background Email campaign
     Exhibition space (6 m²)
    Staff passes (2)Delegate passes (1) Supplements in delegate bags (1)

    3,000 €

     Your logo on the website
    Your logo on advertising material
    Exhibition space (4 m²)
    Staff passes (1)

    Main Sponsors

    biosyn Arzneimittel GmbH is a pharmaceutical and biotech company based in Fellbach, Germany. It specializes in trace elements, is the world market leader in high-dose selenium injections, and is the developer and operator of two globally unique GMP active ingredient manufacturing facilities. In addition, biosyn is active in the biotech sector with a glycoprotein isolated from Megathura crenulata. 
    Active in the fields of oncology, intensive care and endocrinology, biosyn’s products make it a partner for clinics and practicing physicians in the field of integrative medicine, and thus for conventional medicine and naturopathy.


    Pascoe pharmazeutische Präparate GmbH has been manufacturing pharmaceuticals for more than 125 years. The company was founded by Friedrich H. Pascoe and is now managed by his grandson Jürgen F. Pascoe in the third generation. The pharmaceutical manufacturer produces around 200 medicines. Pascoe employs around 200 people and has subsidiaries in Toronto/Canada, Vienna/Austria, Bratislava/Slovakia and in Prague/Czech Republic. 
    The company has received several awards as best employer in Germany and Europe.
    Since 1975, Helixor has been a leading pharmaceutical company in the field of integrative oncology.
    Oncologists and natural practitioners as well as cancer patients trust in our long-term therapy concepts. Our medicinal products using mistletoe and Christmas rose are assigned special significance for improving cancer patients’ quality of life by relieving typical side effects and enhancing the tolerability of conventional therapies.
    Helixor products are currently registered in 17 countries and sold in more than 70 countries worldwide.
    Continuous research, mindfulness towards people and nature, dedicated personal counseling, the highest quality standards – that is how we deliver on our key goal:         Bringing life to life.
    In the USA, a phase 1 study on intravenous mistletoe therapy has just been successfully completed and published. Find out more at WOCOIO 2023.
    We are a pharmaceutical company that manufactures and scientifically researches plant-based preparations for integrative cancer treatment, especially with mistletoe. This is how we aim to provide support to medical professionals, patients and their relatives, and to contribute to a better quality of life. Our holistic approach focuses not only on the disease but on each person as an individual.
    Powered by the force of nature and the knowledge gained from over 70 years of research at Hiscia Institute in Arlesheim, Switzerland, we work relentlessly to further develop our remedies. It is our ambition to enhance the potential of integrative cancer therapy and to complement conventional medicine in the best way possible. It is equally important for us to share scientific findings with healthcare professionals in order to optimally support them in treating their patients.
    ABNOBA GmbH is an independent, medium-sized, research-based pharmaceutical manufacturer based in Niefern-Oeschelbronn, Germany. The partners of ABNOBA GmbH are exclusively non-profit organisations. The profits from our company are therefore particularly channelled into cancer research. Oncology patients are the focus of our activity. ABNOBA GmbH is one of the world’s leading and most innovative companies in the field of herbal medicinal products for oncology.
    At NORSAN we are a Norwegian company specializing in high-quality omega-3 products. NORSAN is the No. 1 brand for omega-3 products in pharmacies, for which we are very grateful.
    Our company goals are:
    1. To provide information about omega-3 products fatty acids and how they work
    2. Improve omega-3 supply by offering quality omega-3 products
    With the help of professional advice, lectures and information material, we would like to be a good partner and support you in your omega-3 advice. To provide you with a full range of therapeutic concept, we offer the option of an individual blood-test to know your omega-3 levels. The education for a healthy nutrition is one of our main goals of our team. 
    The company is increasingly engaged in the field of nutraceutical pharmaceutical research and development. With the aim of improving people’s lives through an approach that integrates different multidisciplinary skills, innovative technologies, remedies offered by nature and solid ethical principles. Thanks to a well-established national and international scientific network, which continues to grow over the years with the collaboration of various qualified doctors, institutes and prestigious universities.
    A work, ours, that aims straight at innovation, quality, the most interesting patents in the world and clinical and laboratory experience to achieve high standards and affirmation in the planet Farma!
    CeGaT is a global provider of genetic analyses for a wide range of medical, research, and pharmaceutical applications.
    Founded in 2009 in Tübingen, Germany, the company combines state-of-the-art sequencing technology with medical expertise – with the aim of identifying the genetic causes of diseases and supporting patient care. 
    The owner-managed company stands for independence, comprehensive personal customer service, and outstanding quality. CeGaT’s laboratory is accredited according to CAP/CLIA, DIN EN ISO 15189, and DIN EN ISO/IEC 17025 and thus meets the highest international standards. To obtain first-class results, all processes are carried out in-house under scientific supervision.
    heckel is a leading company for hyperthermia devices in strategic partnership with the manufacturer Hydrosun. We are the world-wide exclusive distributor of the whole-body hyperthermia device heckel-HT3000 (for oncological and non-oncological indications) and the thermography-controlled water-filtered infrared A (wIRA) superficial hyperthermia device hydrosun®TWH1500 (used as radiosensitizer for oncological indications). Aartal-Apotheke is an online Pharmacy that specializes in shipping naturpathic medicines worldwide.

    “Awaken the power of the cells!” – according to this motto, the vitOrgan Arzneimittel GmbH has been producing organ homeopathic injection preparations for almost 70 years. They are used for successful therapy, especially in the areas of geriatrics, orthopedics, adjuvant tumor therapy and allergology / immunology, as well as for general revitalization – in each case individually matched to the person.
    For this purpose, the natural regulatory and metabolic cell substances of young healthy cells are used to regulate and normalize the processes that have become unbalanced during an illness. Self-healing mechanisms are set in motion and patients are thus treated not only symptomatically, but causally.


    iQMedix performs personalized precision diagnostics from Circulating Tumor Cells (CTC) from the individual cancer patients blood in order to enable highly effective precision treatments with minimal side effects. We employ the proven Metavectum® gene expression testing. It delivers a comprehensive panel of individual activity levels of signaling and metabolic pathways of a specific cancer. With that the individual sensitivity of a cancer to complementary agents, off-label drugs or chemo-agents can be understood. Highly precise personal therapeutic options can be derived by the medical practitioner to extend the patients life span and quality of life.

    Subscribe to our newsletter

    If you wish to stay up-to-date on the latest news of the WOCOIO, simply fill in this form and we will contact you shortly.